Should patients in quality-improvement activities have the same protections as participants in research studies? [4] (multiple letters)

JAMA

Volumn 284, Issue 14, 2000, Pages 1786-1788

  Cretin, S ^a   Keeler, E B ^a   Lynn, J ^a   Batalden, P B ^a   Berwick, D M ^a   Bisognano, M ^a   Cooper, J A ^a   Chernov, A J ^a   Warburton, S W ^a   Hayley, D C ^a   Casarett, D ^a   Karlawish, J H T ^a   Sugarman, J ^a  

^a RAND CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABUSE; CLINICAL PROTOCOL; CLINICAL RESEARCH; HEALTH CARE POLICY; HEALTH CARE QUALITY; INFORMED CONSENT; LETTER; MEDICAL ETHICS; METHODOLOGY; PATIENT RIGHT; PRIORITY JOURNAL; QUALITY CONTROL; RISK ASSESSMENT; BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH; HUMAN; NOTE; PRACTICE GUIDELINE; RESEARCH; STANDARD; UNITED STATES;

BIOMEDICAL AND BEHAVIORAL RESEARCH; HEALTH CARE AND PUBLIC HEALTH;

GUIDELINES; HUMANS; QUALITY CONTROL; QUALITY OF HEALTH CARE; RESEARCH; UNITED STATES; HEALTH POLICY;

EID: 0034638285     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.284.14.1786     Document Type: Letter

References (0)